Knowledge Center

Article / Jun 08, 2009

The View From New Jersey

Authors:
Source:
C&EN, 8 June, 2009

In the spring of 2003, ËÄÉ«AV opened a small-scale production facility in East Windsor, N.J. As its name implies, the $20 million Technology Transfer Center was intended as a place to develop customers' molecules before moving them to headquarters in Loures, Portugal, for scale-up. Given ËÄÉ«AV's target market of small to midsized drug companies, TTC was meant to boost business with U.S. biotech firms.

Related links

Also in the Knowledge Center

Related Content

Spray drying

Spray drying has become one of the most successful particle engineering technologies for improving drug bioavailability through the amorphous solid dispersion platform.

Page
Read more

Drug Product Manufacturing

To extend ËÄÉ«AV further we are now able to offer clinical supplies manufacturing for drug products.

Page
Read more

Continuous Flow

Expand the established chemistry space with Continuous Flow to deliver robust and sustainable processes.

Page
Read more